GUARDANT HEALTH INC's ticker is GH and the CUSIP is 40131M109. A total of 332 filers reported holding GUARDANT HEALTH INC in Q3 2022. The put-call ratio across all filers is 0.85 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $21,480 | +46.6% | 600 | -4.0% | 0.00% | – |
| Q1 2023 | $14,650 | +91462.5% | 625 | +4.2% | 0.00% | – |
| Q4 2022 | $16 | -100.0% | 600 | 0.0% | 0.00% | -100.0% |
| Q3 2022 | $32,000 | +33.3% | 600 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $24,000 | -40.0% | 600 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $40,000 | -46.7% | 600 | -20.0% | 0.00% | -50.0% |
| Q4 2021 | $75,000 | 0.0% | 750 | +25.0% | 0.00% | 0.0% |
| Q3 2021 | $75,000 | 0.0% | 600 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $75,000 | -18.5% | 600 | 0.0% | 0.00% | -33.3% |
| Q1 2021 | $92,000 | +19.5% | 600 | 0.0% | 0.00% | +50.0% |
| Q4 2020 | $77,000 | +14.9% | 600 | 0.0% | 0.00% | -33.3% |
| Q3 2020 | $67,000 | +36.7% | 600 | 0.0% | 0.00% | +50.0% |
| Q2 2020 | $49,000 | +16.7% | 600 | 0.0% | 0.00% | 0.0% |
| Q1 2020 | $42,000 | -10.6% | 600 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $47,000 | – | 600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 390,945 | $39,102,000 | 11.96% |
| Iron Triangle Partners LP | 440,255 | $44,034,000 | 6.14% |
| Adalta Capital Management LLC | 110,260 | $11,028,000 | 5.08% |
| Ally Bridge Group (NY) LLC | 105,000 | $10,502,000 | 3.67% |
| Eagle Health Investments LP | 119,360 | $11,938,000 | 2.91% |
| Casdin Capital, LLC | 790,000 | $79,016,000 | 2.23% |
| AtonRa Partners | 54,163 | $5,417,000 | 1.88% |
| Steadfast Capital Management (UK) Ltd. | 14,686 | $1,469,000 | 1.77% |
| STEADFAST CAPITAL MANAGEMENT LP | 1,009,031 | $100,923,000 | 1.66% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 74,500 | $7,451,000 | 1.66% |